Antibiotic Resistance: Understanding and Responding to an Emerging Crisis. Este artículo no está disponible.
Drlica, Karl S.,Perlin, David S.
Idioma: inglés
Editorial: Financial Times/ Prentice Hall, 2011
- Tapa dura
- Usado
Librería: Sell Books, Elland, Yorks, Reino UnidoSell Books
Vendedor de IberLibro desde 27 de diciembre de 2024
Condición: Usado - Regular
EUR 45,27
Descripción del artículo del vendedor
Please see the condition note after this for details, if this is missing please consider Acceptable to mean poor quality that could include major staining, water damage, writing, missing dustjacket, etc etc. Our books are dispatched from a Yorkshire former cotton mill. We list via barcode/ISBN so please note that the images are stock images and may not be the exact copy you receive, furthermore the details about edition and year might not be accurate as many publishers reuse the same ISBN for multiple editions and as we simply scan a barcode or enter an ISBN we do not check the validity of the edition data when listing. If you're looking for an exact edition please don't order (at least not without checking with us first, although we don't always have time to check). We aim to dispatch prompty, the service used will depend on order value and book size. We can ship to most countries, see our shipping policies. Payment is via Abe only.
N° de ref. del artículo P-BGI00507-RAG-20250513-A
- Título
- Antibiotic Resistance: Understanding and Responding to an Emerging Crisis
- Autor
- Drlica, Karl S.,Perlin, David S.
- Editorial
- Financial Times/ Prentice Hall
- Año de publicación
- 2011
- Estado
- Acceptable
- Sobrecubierta
- Sobrecubierta Incluida
- Encuadernación
- hardcover
- Idioma
- inglés
- ISBN 10
- 0131387731
- ISBN 13
- 9780131387737
- Serie
- Libro 8 de 15: FT Press Science
Authored by two leading investigators, this book presents a thorough and authoritative overview of this multifaceted field of science. Pathogenic bacteria have been evolving and spreading resistance to diverse classes of antibiotics. As a result, we risk losing our ability to control and treat infectious diseases. Understanding antibiotic resistance, therefore, is becoming increasingly essential for a broad audience of healthcare professionals, biomedical and public health researchers, students, and policymakers. The authors answer questions such as: What is resistance? How does it emerge? How do common human activities contribute to resistance? What can we do about it? How can we strengthen our “first lines of defense” against resistance? Are there better ways to discover new antibiotics? What unique issues are associated with MRSA and viral influenza? In addition to defining and evaluating one of the most important emerging threats to public health, the authors explain what can be done to minimize risks to public health, and to preserve and extend the effectiveness of existing and new antibiotics.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Karl Drlica, Ph.D. is a Principal Investigator at the Public Health Research Institute and Professor of Microbiology & Molecular Genetics at the UMDNJ–New Jersey Medical School in Newark. His laboratory focuses on fluoroquinolone action and resistance with Mycobacteriun tuberculosis and other bacteria, including approaches for slowing the enrichment and amplification of resistant bacterial subpopulations.
David S. Perlin, Ph.D. is Executive Director of the Public Health Research Institute and UMDNJ Regional Biocontainment Laboratory, as well as Professor of Microbiology & Molecular Genetics at the New Jersey Medical School in Newark. He is also a Fellow of the New York Academy of Sciences. Dr. Perlin’s laboratory explores mechanisms of antifungal drug-resistance, rapid detection of drug resistant bloodstream pathogens in high-risk patients, and the application of small-animal models for the study of respiratory pathogens.
“Acerca de” puede pertenecer a otra edición de este título.